Optipac® Refobacin® Bone Cement R - Orthopaedic cement, medicated - ARTG 450207
Access comprehensive regulatory information for Optipac® Refobacin® Bone Cement R - Orthopaedic cement, medicated in the Australia medical device market through Pure Global AI's free TGA ARTG database. This Class III is registered under ARTG number 450207 and sponsored by Zimmer Biomet Pty Ltd, manufactured by Biomet France in France. The device registration started on May 30, 2024.
This page provides complete registration details including sponsor information, manufacturer details, and regulatory compliance data from the official Australia TGA ARTG medical device database. Pure Global AI offers free access to Australia's complete medical device registry with 131,000+ devices, helping global MedTech companies navigate TGA regulations efficiently.
Optipac® Refobacin® Bone Cement R is indicated to be used for stable anchoring of suitable joint prostheses to the bone, in hip and knee primary arthroplasty operations, also in case an infection with gentamicin-sensitive strains is a potential risk.